In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, cilt.41, sa.5, ss.1156-1157, 1997 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 41 Sayı: 5
- Basım Tarihi: 1997
- Doi Numarası: 10.1128/aac.41.5.1156
- Dergi Adı: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1156-1157
- Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır
Özet
The in vitro activity of LY303366, a new echinocandin derivative, was evaluated with 191 yeast isolates by a broth microdilution method. The MICs at which 50% of the isolates were inhibited were 0.125 mu g/ml for Candida albicans and C. tropicalis, 0.25 mu g/ml for C. krusei, C. kefyr, and C. glabrata, and 2.0 mu g/ml for C. parapsilosis.